CTI (Computerized Thermal Imaging) hits back at FDA over breast imaging PMA (Pre-market Approval) decision
This article was originally published in Clinica
Computerized Thermal Imaging (CTI) is trying unusually aggressive tactics after failing to win FDA approval for its thermal breast imaging device. The company filed a citizen petition with the agency late last month, demanding that the agency correct the administrative record on its premarket approval application, claiming that "pervasive bias" by the review staff "severely and improperly prejudiced" the submission.
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.